Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Negri Ea"'
Autor:
Ascierto Pa, Cristina Mussini, Marco Massari, Giovanni Dolci, Francesco Castelli, Claudia Cardone, Cascella M, G. Botti, Marata Am, Maria Carmela Piccirillo, Patrizia Popoli, Schettino C, Piera Gargiulo, Ciro Gallo, Montesarchio, Adriano Gravina, Carlo Salvarani, costantini m, Nicola Squillace, Fraganza F, Negri Ea, Arenare L, Salerno Nd, Miriam Lichtner, Paolo Bonfanti, Facciolongo Nc, Diego Ripamonti, Maria Lorenza Muiesan, Ferraris L, Paolo Chiodini, Calzetti C, Marrocco Trischitta Mm, Binda F, Perrone F, Parrella R, Atripaldi L
BackgroundTocilizumab blocks pro-inflammatory activity of interleukin-6 (IL-6), involved in pathogenesis of pneumonia the most frequent cause of death in COVID-19 patients.MethodsA multicentre, single-arm, hypothesis-driven phase 2 trial was planned
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bd1f3ca9ef1e60c5e256914963d9f679
